Lucas Hahn

Lucas Hahn

InvestorPlace Contributor

Lucas Hahn graduated from the University of California, Irvine in June 2013 with bachelor’s degrees in international studies and political science. A longtime passion of his has been the financial markets, particularly with regards to China. He currently teaches English to children in Taiwan and is learning Mandarin.

Recent Articles

Is Target Corporation Stock on Sale?

By Lucas Hahn, InvestorPlace Contributor

Competition among grocery retailers is heating up, and this could impact Target and hurt TGT stock owners.

After a Lackluster 2017, Is It Time to Sell Walt Disney Co Stock?

By Lucas Hahn, InvestorPlace Contributor

Disney had an unexciting year, with all but one division shrinking, but is this cause for concern for Walt Disney stock?

3 Things to Fall in Love With About Square Inc Stock

By Lucas Hahn, InvestorPlace Contributor

Square Inc's revenue growth is not slowing down, Square stock is diversifying its gross profits, and its gross margin is holding steady.

Facebook Inc Needs to Address Its Biggest Weakness Before Trouble Starts

By Lucas Hahn, InvestorPlace Contributor

Facebook needs to diversify its sources of revenue if it wants to maintain this year's 50%-plus gain in FB stock.

Should You Buy Netflix, Inc. Stock? 3 Pros, 3 Cons

By Lucas Hahn, InvestorPlace Contributor

NFLX earnings have shown impressive growth, and Netflix stock has grown in both volume and pricing, but the stock is not without risks.

3 Reasons Why Ambarella Inc (AMBA) Stock Is a Great Buy

By Lucas Hahn, InvestorPlace Contributor

A string of acquisitions in the emerging field of computer vision makes Ambarella (AMBA) stock appear interesting.

3 Pros, 3 Cons for Buying Kroger Co (KR) Stock

By Lucas Hahn, InvestorPlace Contributor

Is the market correctly pricing KR stock on fears of increased competition, or are investors being too hard on Kroger?

Could Being Undervalued Boost Rite Aid (RAD) Stock?

By Lucas Hahn, InvestorPlace Contributor

Rite Aid has a market cap of $2.44 billion, but it bought EnvisionRx for $1.8 billion in 2015. Does this make it undervalued?

Advanced Micro Devices, Inc. (AMD) Hopes New Technology Will Challenge Intel

By Lucas Hahn, InvestorPlace Contributor

Advanced Micro Devices, Inc. (NASDAQ:AMD) is gunning for Intel, releasing new products this year and forcing Intel to cut prices.

Chesapeake Energy (CHK) Stock Is Too Uncertain

By Lucas Hahn, InvestorPlace Contributor

The outlook for the future of oil and gas remains uncertain, and Chesapeake Energy's debt load and high beta makes it unattractive.

Load More